Global OTC Consumer Health Products (Powder Form) Market Growth 2020-2025

Publisher Name :
Date: 25-Mar-2020
No. of pages: 136

According to this study, over the next five years the OTC Consumer Health Products (Powder Form) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in OTC Consumer Health Products (Powder Form) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of OTC Consumer Health Products (Powder Form) market by type, application, key manufacturers and key regions and countries.

This study considers the OTC Consumer Health Products (Powder Form) value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Skin Care Products

- Oral Care Products

- Nutritional Supplements

- Wound Care Management Products

- Gastrointestinal Products

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospital Pharmacy

- Independent Pharmacies

- Online Sales

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Pfizer, Inc.

- Johnson & Johnson

- American Health

- GlaxosmithKline plc

- Ipsen, Sanofi S.A.

- Abbott Laboratories

- Sun Pharmaceuticals Ltd.

- Bayer AG

- Glenmark Pharmaceuticals Ltd.

- Piramal Enterprises Ltd.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global OTC Consumer Health Products (Powder Form) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of OTC Consumer Health Products (Powder Form) market by identifying its various subsegments.

- Focuses on the key global OTC Consumer Health Products (Powder Form) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the OTC Consumer Health Products (Powder Form) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of OTC Consumer Health Products (Powder Form) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global OTC Consumer Health Products (Powder Form) Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Consumer Health Products (Powder Form) Consumption 2015-2025
2.1.2 OTC Consumer Health Products (Powder Form) Consumption CAGR by Region
2.2 OTC Consumer Health Products (Powder Form) Segment by Type
2.2.1 Skin Care Products
2.2.2 Oral Care Products
2.2.3 Nutritional Supplements
2.2.4 Wound Care Management Products
2.2.5 Gastrointestinal Products
2.3 OTC Consumer Health Products (Powder Form) Consumption by Type
2.3.1 Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
2.3.2 Global OTC Consumer Health Products (Powder Form) Revenue and Market Share by Type (2015-2020)
2.3.3 Global OTC Consumer Health Products (Powder Form) Sale Price by Type (2015-2020)
2.4 OTC Consumer Health Products (Powder Form) Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Independent Pharmacies
2.4.3 Online Sales
2.4.4 Other
2.5 OTC Consumer Health Products (Powder Form) Consumption by Application
2.5.1 Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
2.5.2 Global OTC Consumer Health Products (Powder Form) Value and Market Share by Type (2015-2020)
2.5.3 Global OTC Consumer Health Products (Powder Form) Sale Price by Type (2015-2020)

3 Global OTC Consumer Health Products (Powder Form) by Company
3.1 Global OTC Consumer Health Products (Powder Form) Sales Market Share by Company
3.1.1 Global OTC Consumer Health Products (Powder Form) Sales by Company (2018-2020)
3.1.2 Global OTC Consumer Health Products (Powder Form) Sales Market Share by Company (2018-2020)
3.2 Global OTC Consumer Health Products (Powder Form) Revenue Market Share by Company
3.2.1 Global OTC Consumer Health Products (Powder Form) Revenue by Company (2018-2020)
3.2.2 Global OTC Consumer Health Products (Powder Form) Revenue Market Share by Company (2018-2020)
3.3 Global OTC Consumer Health Products (Powder Form) Sale Price by Company
3.4 Global OTC Consumer Health Products (Powder Form) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global OTC Consumer Health Products (Powder Form) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players OTC Consumer Health Products (Powder Form) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 OTC Consumer Health Products (Powder Form) by Regions
4.1 OTC Consumer Health Products (Powder Form) by Regions
4.2 Americas OTC Consumer Health Products (Powder Form) Consumption Growth
4.3 APAC OTC Consumer Health Products (Powder Form) Consumption Growth
4.4 Europe OTC Consumer Health Products (Powder Form) Consumption Growth
4.5 Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption Growth

5 Americas
5.1 Americas OTC Consumer Health Products (Powder Form) Consumption by Countries
5.1.1 Americas OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020)
5.1.2 Americas OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020)
5.2 Americas OTC Consumer Health Products (Powder Form) Consumption by Type
5.3 Americas OTC Consumer Health Products (Powder Form) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC OTC Consumer Health Products (Powder Form) Consumption by Regions
6.1.1 APAC OTC Consumer Health Products (Powder Form) Consumption by Regions (2015-2020)
6.1.2 APAC OTC Consumer Health Products (Powder Form) Value by Regions (2015-2020)
6.2 APAC OTC Consumer Health Products (Powder Form) Consumption by Type
6.3 APAC OTC Consumer Health Products (Powder Form) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe OTC Consumer Health Products (Powder Form) by Countries
7.1.1 Europe OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020)
7.1.2 Europe OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020)
7.2 Europe OTC Consumer Health Products (Powder Form) Consumption by Type
7.3 Europe OTC Consumer Health Products (Powder Form) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa OTC Consumer Health Products (Powder Form) by Countries
8.1.1 Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020)
8.2 Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Type
8.3 Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 OTC Consumer Health Products (Powder Form) Distributors
10.3 OTC Consumer Health Products (Powder Form) Customer

11 Global OTC Consumer Health Products (Powder Form) Market Forecast
11.1 Global OTC Consumer Health Products (Powder Form) Consumption Forecast (2021-2025)
11.2 Global OTC Consumer Health Products (Powder Form) Forecast by Regions
11.2.1 Global OTC Consumer Health Products (Powder Form) Forecast by Regions (2021-2025)
11.2.2 Global OTC Consumer Health Products (Powder Form) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global OTC Consumer Health Products (Powder Form) Forecast by Type
11.8 Global OTC Consumer Health Products (Powder Form) Forecast by Application

12 Key Players Analysis
12.1 Pfizer, Inc.
12.1.1 Company Information
12.1.2 OTC Consumer Health Products (Powder Form) Product Offered
12.1.3 Pfizer, Inc. OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer, Inc. Latest Developments
12.2 Johnson & Johnson
12.2.1 Company Information
12.2.2 OTC Consumer Health Products (Powder Form) Product Offered
12.2.3 Johnson & Johnson OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Johnson & Johnson Latest Developments
12.3 American Health
12.3.1 Company Information
12.3.2 OTC Consumer Health Products (Powder Form) Product Offered
12.3.3 American Health OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 American Health Latest Developments
12.4 GlaxosmithKline plc
12.4.1 Company Information
12.4.2 OTC Consumer Health Products (Powder Form) Product Offered
12.4.3 GlaxosmithKline plc OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 GlaxosmithKline plc Latest Developments
12.5 Ipsen, Sanofi S.A.
12.5.1 Company Information
12.5.2 OTC Consumer Health Products (Powder Form) Product Offered
12.5.3 Ipsen, Sanofi S.A. OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Ipsen, Sanofi S.A. Latest Developments
12.6 Abbott Laboratories
12.6.1 Company Information
12.6.2 OTC Consumer Health Products (Powder Form) Product Offered
12.6.3 Abbott Laboratories OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Abbott Laboratories Latest Developments
12.7 Sun Pharmaceuticals Ltd.
12.7.1 Company Information
12.7.2 OTC Consumer Health Products (Powder Form) Product Offered
12.7.3 Sun Pharmaceuticals Ltd. OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sun Pharmaceuticals Ltd. Latest Developments
12.8 Bayer AG
12.8.1 Company Information
12.8.2 OTC Consumer Health Products (Powder Form) Product Offered
12.8.3 Bayer AG OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Bayer AG Latest Developments
12.9 Glenmark Pharmaceuticals Ltd.
12.9.1 Company Information
12.9.2 OTC Consumer Health Products (Powder Form) Product Offered
12.9.3 Glenmark Pharmaceuticals Ltd. OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Glenmark Pharmaceuticals Ltd. Latest Developments
12.10 Piramal Enterprises Ltd.
12.10.1 Company Information
12.10.2 OTC Consumer Health Products (Powder Form) Product Offered
12.10.3 Piramal Enterprises Ltd. OTC Consumer Health Products (Powder Form) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Piramal Enterprises Ltd. Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. OTC Consumer Health Products (Powder Form) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Skin Care Products
Table 5. Major Players of Oral Care Products
Table 6. Major Players of Nutritional Supplements
Table 7. Major Players of Wound Care Management Products
Table 8. Major Players of Gastrointestinal Products
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Table 11. Global OTC Consumer Health Products (Powder Form) Revenue by Type (2015-2020) ($ million)
Table 12. Global OTC Consumer Health Products (Powder Form) Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global OTC Consumer Health Products (Powder Form) Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Table 16. Global OTC Consumer Health Products (Powder Form) Value by Application (2015-2020)
Table 17. Global OTC Consumer Health Products (Powder Form) Value Market Share by Application (2015-2020)
Table 18. Global OTC Consumer Health Products (Powder Form) Sale Price by Application (2015-2020)
Table 19. Global OTC Consumer Health Products (Powder Form) Sales by Company (2017-2019) (Kiloton)
Table 20. Global OTC Consumer Health Products (Powder Form) Sales Market Share by Company (2017-2019)
Table 21. Global OTC Consumer Health Products (Powder Form) Revenue by Company (2017-2019) ($ Millions)
Table 22. Global OTC Consumer Health Products (Powder Form) Revenue Market Share by Company (2017-2019)
Table 23. Global OTC Consumer Health Products (Powder Form) Sale Price by Company (2017-2019)
Table 24. Global OTC Consumer Health Products (Powder Form) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players OTC Consumer Health Products (Powder Form) Products Offered
Table 26. OTC Consumer Health Products (Powder Form) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global OTC Consumer Health Products (Powder Form) Consumption by Regions 2015-2020 (Kiloton)
Table 28. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Regions 2015-2020
Table 29. Global OTC Consumer Health Products (Powder Form) Value by Regions 2015-2020 ($ Millions)
Table 30. Global OTC Consumer Health Products (Powder Form) Value Market Share by Regions 2015-2020
Table 31. Americas OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020) (Kiloton)
Table 32. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries (2015-2020)
Table 33. Americas OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020) ($ Millions)
Table 34. Americas OTC Consumer Health Products (Powder Form) Value Market Share by Countries (2015-2020)
Table 35. Americas OTC Consumer Health Products (Powder Form) Consumption by Type (2015-2020) (Kiloton)
Table 36. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Table 37. Americas OTC Consumer Health Products (Powder Form) Consumption by Application (2015-2020) (Kiloton)
Table 38. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Table 39. APAC OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020) (Kiloton)
Table 40. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries (2015-2020)
Table 41. APAC OTC Consumer Health Products (Powder Form) Value by Regions (2015-2020) ($ Millions)
Table 42. APAC OTC Consumer Health Products (Powder Form) Value Market Share by Regions (2015-2020)
Table 43. APAC OTC Consumer Health Products (Powder Form) Consumption by Type (2015-2020) (Kiloton)
Table 44. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Table 45. APAC OTC Consumer Health Products (Powder Form) Consumption by Application (2015-2020) (Kiloton)
Table 46. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Table 47. Europe OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020) (Kiloton)
Table 48. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries (2015-2020)
Table 49. Europe OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020) ($ Millions)
Table 50. Europe OTC Consumer Health Products (Powder Form) Value Market Share by Countries (2015-2020)
Table 51. Europe OTC Consumer Health Products (Powder Form) Consumption by Type (2015-2020) (Kiloton)
Table 52. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Table 53. Europe OTC Consumer Health Products (Powder Form) Consumption by Application (2015-2020) (Kiloton)
Table 54. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Countries (2015-2020) (Kiloton)
Table 56. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa OTC Consumer Health Products (Powder Form) Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa OTC Consumer Health Products (Powder Form) Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Type (2015-2020) (Kiloton)
Table 60. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption by Application (2015-2020) (Kiloton)
Table 62. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Table 63. OTC Consumer Health Products (Powder Form) Distributors List
Table 64. OTC Consumer Health Products (Powder Form) Customer List
Table 65. Global OTC Consumer Health Products (Powder Form) Consumption Forecast by Countries (2021-2025) (Kiloton)
Table 66. Global OTC Consumer Health Products (Powder Form) Consumption Market Forecast by Regions
Table 67. Global OTC Consumer Health Products (Powder Form) Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global OTC Consumer Health Products (Powder Form) Value Market Share Forecast by Regions
Table 69. Global OTC Consumer Health Products (Powder Form) Consumption Forecast by Type (2021-2025) (Kiloton)
Table 70. Global OTC Consumer Health Products (Powder Form) Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global OTC Consumer Health Products (Powder Form) Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global OTC Consumer Health Products (Powder Form) Value Market Share Forecast by Type (2021-2025)
Table 73. Global OTC Consumer Health Products (Powder Form) Consumption Forecast by Application (2021-2025) (Kiloton)
Table 74. Global OTC Consumer Health Products (Powder Form) Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global OTC Consumer Health Products (Powder Form) Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global OTC Consumer Health Products (Powder Form) Value Market Share Forecast by Application (2021-2025)
Table 77. Pfizer, Inc. Product Offered
Table 78. Pfizer, Inc. OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 79. Pfizer, Inc. Main Business
Table 80. Pfizer, Inc. Latest Developments
Table 81. Pfizer, Inc. Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 82. Johnson & Johnson Product Offered
Table 83. Johnson & Johnson OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 87. American Health Product Offered
Table 88. American Health OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 89. American Health Main Business
Table 90. American Health Latest Developments
Table 91. American Health Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxosmithKline plc Product Offered
Table 93. GlaxosmithKline plc OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 94. GlaxosmithKline plc Main Business
Table 95. GlaxosmithKline plc Latest Developments
Table 96. GlaxosmithKline plc Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 97. Ipsen, Sanofi S.A. Product Offered
Table 98. Ipsen, Sanofi S.A. OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 99. Ipsen, Sanofi S.A. Main Business
Table 100. Ipsen, Sanofi S.A. Latest Developments
Table 101. Ipsen, Sanofi S.A. Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbott Laboratories Product Offered
Table 103. Abbott Laboratories OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 104. Abbott Laboratories Main Business
Table 105. Abbott Laboratories Latest Developments
Table 106. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 107. Sun Pharmaceuticals Ltd. Product Offered
Table 108. Sun Pharmaceuticals Ltd. Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceuticals Ltd. Main Business
Table 110. Sun Pharmaceuticals Ltd. Latest Developments
Table 111. Sun Pharmaceuticals Ltd. OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 112. Bayer AG Product Offered
Table 113. Bayer AG OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 114. Bayer AG Main Business
Table 115. Bayer AG Latest Developments
Table 116. Bayer AG Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 117. Glenmark Pharmaceuticals Ltd. Product Offered
Table 118. Glenmark Pharmaceuticals Ltd. OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 119. Glenmark Pharmaceuticals Ltd. Main Business
Table 120. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 121. Glenmark Pharmaceuticals Ltd. Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors
Table 122. Piramal Enterprises Ltd. Product Offered
Table 123. Piramal Enterprises Ltd. OTC Consumer Health Products (Powder Form) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 124. Piramal Enterprises Ltd. Main Business
Table 125. Piramal Enterprises Ltd. Latest Developments
Table 126. Piramal Enterprises Ltd. Basic Information, Company Total Revenue (in $ million), OTC Consumer Health Products (Powder Form) Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of OTC Consumer Health Products (Powder Form)
Figure 2. OTC Consumer Health Products (Powder Form) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global OTC Consumer Health Products (Powder Form) Consumption Growth Rate 2015-2025 (Kiloton)
Figure 5. Global OTC Consumer Health Products (Powder Form) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Skin Care Products
Figure 7. Product Picture of Oral Care Products
Figure 8. Product Picture of Nutritional Supplements
Figure 9. Product Picture of Wound Care Management Products
Figure 10. Product Picture of Gastrointestinal Products
Figure 11. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Type (2015-2020)
Figure 12. Global OTC Consumer Health Products (Powder Form) Value Market Share by Type (2015-2020)
Figure 13. OTC Consumer Health Products (Powder Form) Consumed in Hospital Pharmacy
Figure 14. Global OTC Consumer Health Products (Powder Form) Market: Hospital Pharmacy (2015-2020) (Kiloton)
Figure 15. Global OTC Consumer Health Products (Powder Form) Market: Hospital Pharmacy (2015-2020) ($ Millions)
Figure 16. OTC Consumer Health Products (Powder Form) Consumed in Independent Pharmacies
Figure 17. Global OTC Consumer Health Products (Powder Form) Market: Independent Pharmacies (2015-2020) (Kiloton)
Figure 18. Global OTC Consumer Health Products (Powder Form) Market: Independent Pharmacies (2015-2020) ($ Millions)
Figure 19. OTC Consumer Health Products (Powder Form) Consumed in Online Sales
Figure 20. Global OTC Consumer Health Products (Powder Form) Market: Online Sales (2015-2020) (Kiloton)
Figure 21. Global OTC Consumer Health Products (Powder Form) Market: Online Sales (2015-2020) ($ Millions)
Figure 22. OTC Consumer Health Products (Powder Form) Consumed in Other
Figure 23. Global OTC Consumer Health Products (Powder Form) Market: Other (2015-2020) (Kiloton)
Figure 24. Global OTC Consumer Health Products (Powder Form) Market: Other (2015-2020) ($ Millions)
Figure 25. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Application (2015-2020)
Figure 26. Global OTC Consumer Health Products (Powder Form) Value Market Share by Application (2015-2020)
Figure 27. Global OTC Consumer Health Products (Powder Form) Sales Market Share by Company in 2017
Figure 28. Global OTC Consumer Health Products (Powder Form) Sales Market Share by Company in 2019
Figure 29. Global OTC Consumer Health Products (Powder Form) Revenue Market Share by Company in 2017
Figure 30. Global OTC Consumer Health Products (Powder Form) Revenue Market Share by Company in 2019
Figure 31. Global OTC Consumer Health Products (Powder Form) Sale Price by Company in 2019
Figure 32. Global OTC Consumer Health Products (Powder Form) Consumption Market Share by Regions 2015-2020
Figure 33. Global OTC Consumer Health Products (Powder Form) Value Market Share by Regions 2015-2020
Figure 34. Americas OTC Consumer Health Products (Powder Form) Consumption 2015-2020 (Kiloton)
Figure 35. Americas OTC Consumer Health Products (Powder Form) Value 2015-2020 ($ Millions)
Figure 36. APAC OTC Consumer Health Products (Powder Form) Consumption 2015-2020 (Kiloton)
Figure 37. APAC OTC Consumer Health Products (Powder Form) Value 2015-2020 ($ Millions)
Figure 38. Europe OTC Consumer Health Products (Powder Form) Consumption 2015-2020 (Kiloton)
Figure 39. Europe OTC Consumer Health Products (Powder Form) Value 2015-2020 ($ Millions)
Figure 40. Middle East & Africa OTC Consumer Health Products (Powder Form) Consumption 2015-2020 (Kiloton)
Figure 41. Middle East & Africa OTC Consumer Health Products (Powder Form) Value 2015-2020 ($ Millions)
Figure 42. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries in 2019
Figure 43. Americas OTC Consumer Health Products (Powder Form) Value Market Share by Countries in 2019
Figure 44. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Type in 2019
Figure 45. Americas OTC Consumer Health Products (Powder Form) Consumption Market Share by Application in 2019
Figure 46. United States OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 47. United States OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 48. Canada OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 49. Canada OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 50. Mexico OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 51. Mexico OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 52. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries in 2019
Figure 53. APAC OTC Consumer Health Products (Powder Form) Value Market Share by Regions in 2019
Figure 54. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Type in 2019
Figure 55. APAC OTC Consumer Health Products (Powder Form) Consumption Market Share by Application in 2019
Figure 56. China OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 57. China OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 58. Japan OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 59. Japan OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 60. Korea OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 61. Korea OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 62. Southeast Asia OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 63. Southeast Asia OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 64. India OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 65. India OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 66. Australia OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 67. Australia OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 68. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Countries in 2019
Figure 69. Europe OTC Consumer Health Products (Powder Form) Value Market Share by Countries in 2019
Figure 70. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Type in 2019
Figure 71. Europe OTC Consumer Health Products (Powder Form) Consumption Market Share by Application in 2019
Figure 72. Germany OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 73. Germany OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 74. France OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 75. France OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 76. UK OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 77. UK OTC Consumer Health Products (Powder Form) Value Growth 2015-2020 ($ Millions)
Figure 78. Italy OTC Consumer Health Products (Powder Form) Consumption Growth 2015-2020 (Kiloton)
Figure 79. Italy OTC Consumer Health Products (Powder Form) Value Growth 2
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs